Value
3.7/10data confidence 33%| Component | Sub-score |
|---|---|
| P/S | 0.3 |
| Analyst target | 6.0 |
KMTS · Why this verdict
Why Kestra Medical Technologies, Lt (KMTS) is rated BUY WAIT
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
VerdictBUY WAIT
Overall score5.1/10
ConfidenceMEDIUM
MacroRISK_OFF
TrendMatrix Research · core thesis
Engine thesis — one sentence
Exceptional revenue growth near 63% per year and three consecutive earnings beats demonstrate strong commercial momentum, but deeply negative free cash flow consuming roughly 89% of revenues, below-floor business quality, and a technical setup that has not yet confirmed a resumption of trend strength combine to limit the investable case despite the growth trajectory.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
Thesis pillars
| Pillar | Expectation | Trend |
|---|---|---|
Revenue growing at approximately 63% per year places this company among the fastest-growing names in its industry, indicating early-stage market penetration and robust product adoption that could sustain a premium valuation as the growth profile matures. Growth breakdown | Revenue growth rate remains above 40% per year for at least two of the next four reported quarters. | →Stable |
| CounterHypergrowth at this rate typically requires heavy capital investment; with free cash flow deeply negative as a proportion of revenue, the growth is funded by dilution or incremental debt — a pace that cannot be sustained indefinitely without improving unit economics. | ||
Following a large miss at the oldest point in the lookback, the company has beaten consensus estimates in three consecutive quarters — with beats ranging from roughly 20% to over 50% above expectations — suggesting guidance discipline has improved and loss-narrowing is tracking ahead of plan. Earnings | EPS beats continue in at least two of the next three reported quarters, with the reported loss per share continuing to narrow toward breakeven. | →Stable |
| CounterAll four quarters are still losses; if operational scale benefits do not materialize on schedule, the beat streak could end abruptly as it did in the prior period's large negative surprise. | ||
Free cash flow is running at negative 89% of revenues, meaning the company consumes nearly its entire revenue base in cash — a rate of capital depletion that requires frequent external financing and creates ongoing dilution risk for existing shareholders. Quality breakdown | Free cash flow as a percentage of revenue improves to better than negative 50% within four reported quarters as operating leverage begins to narrow the gap. | →Stable |
| CounterAt 63% revenue growth, near-term cash consumption is partly a deliberate investment in growth infrastructure; if gross margins hold and the growth rate is justified by the market opportunity, the cash burn as a share of revenue could narrow faster than a steady-state analysis implies. | ||
Although the stock sits below its 200-day moving average, that average itself is still rising — a configuration consistent with a temporary pullback within an intact longer-term uptrend rather than a structural breakdown. Momentum breakdown | Price reclaims the 200-day moving average within 60 days and holds above it for at least 15 consecutive sessions. | ↓Deteriorating |
| CounterFalling on-balance volume alongside the current technical weakness indicates institutional sellers are active at these levels; if their selling pressure continues, the still-rising moving average could flatten and then turn negative, converting this pullback into a genuine trend reversal. | ||
Revenue growing at approximately 63% per year places this company among the fastest-growing names in its industry, indicating early-stage market penetration and robust product adoption that could sustain a premium valuation as the growth profile matures.
→StableGrowth breakdown
- Expectation
- Revenue growth rate remains above 40% per year for at least two of the next four reported quarters.
CounterHypergrowth at this rate typically requires heavy capital investment; with free cash flow deeply negative as a proportion of revenue, the growth is funded by dilution or incremental debt — a pace that cannot be sustained indefinitely without improving unit economics.
Following a large miss at the oldest point in the lookback, the company has beaten consensus estimates in three consecutive quarters — with beats ranging from roughly 20% to over 50% above expectations — suggesting guidance discipline has improved and loss-narrowing is tracking ahead of plan.
→StableEarnings
- Expectation
- EPS beats continue in at least two of the next three reported quarters, with the reported loss per share continuing to narrow toward breakeven.
CounterAll four quarters are still losses; if operational scale benefits do not materialize on schedule, the beat streak could end abruptly as it did in the prior period's large negative surprise.
Free cash flow is running at negative 89% of revenues, meaning the company consumes nearly its entire revenue base in cash — a rate of capital depletion that requires frequent external financing and creates ongoing dilution risk for existing shareholders.
→StableQuality breakdown
- Expectation
- Free cash flow as a percentage of revenue improves to better than negative 50% within four reported quarters as operating leverage begins to narrow the gap.
CounterAt 63% revenue growth, near-term cash consumption is partly a deliberate investment in growth infrastructure; if gross margins hold and the growth rate is justified by the market opportunity, the cash burn as a share of revenue could narrow faster than a steady-state analysis implies.
Although the stock sits below its 200-day moving average, that average itself is still rising — a configuration consistent with a temporary pullback within an intact longer-term uptrend rather than a structural breakdown.
↓DeterioratingMomentum breakdown
- Expectation
- Price reclaims the 200-day moving average within 60 days and holds above it for at least 15 consecutive sessions.
CounterFalling on-balance volume alongside the current technical weakness indicates institutional sellers are active at these levels; if their selling pressure continues, the still-rising moving average could flatten and then turn negative, converting this pullback into a genuine trend reversal.
Per-dimension breakdown
Quality
4.1/10data confidence 100%| Component | Sub-score |
|---|---|
| ROE | 0.0 |
| ROA | 0.0 |
| Gross margin | 6.3 |
| Current ratio | 8.6 |
| FCF quality | 0.0 |
| Moat | 7.2 |
| Piotroski F | 6.7 |
- ▸Cash-burning: FCF -80% of revenue
Growth
10.0/10data confidence 33%| Component | Sub-score |
|---|---|
| Rev growth | 10.0 |
- ▸Strong growth: 66% YoY
Momentum
1.9/10data confidence 100%| Component | Sub-score |
|---|---|
| RSI | 3.0 |
| MACD | 0.0 |
| OBV | 1.0 |
| MA position | 2.2 |
| Volume | 3.1 |
- ▸Capitulation risk (RSI 19, below 200MA)
- ▸Volume distribution (falling OBV)
- ▸Below 200-MA but MA still rising (+0.1%/30d) — pullback in uptrend, not confirmed weakness
Sentiment
6.5/10data confidence 100%| Component | Sub-score |
|---|---|
| LLM sentiment | 3.0 |
| Analyst rating | 7.7 |
| Price target | 8.7 |
- ▸LLM news sentiment: -0.40 (n=1)
- ▸Light analyst coverage (7.0) — signal dampened
- ▸Analyst upside: 31%
Insider
2.9/10data confidence 100%| Component | Sub-score |
|---|---|
| materiality | 3.0 |
| insider conviction | 2.0 |
| holder change | 3.4 |
| notable moves | 3.0 |
- ▸Notable insider selling — $5,313,485 (0.385% of mkt cap)
Peer rank
4.0/10data confidence 80%| Component | Sub-score |
|---|---|
| value rank | 0.3 |
| quality rank | 0.2 |
| growth rank | 9.3 |
- ▸Industry growth leader
Technical
7.4/10data confidence 100%| Component | Sub-score |
|---|---|
| bollinger | 10.0 |
| support resistance | 9.3 |
| 52w position | 5.2 |
| gap | 5.0 |
Risk (lower is worse)
3.6/10data confidence 80%| Component | Sub-score |
|---|---|
| short interest | 5.2 |
| days to cover | 0.0 |
| volatility | 0.0 |
| debt equity | 9.3 |
- ▸Concentration risks: 1 HIGH (10-K Item 1A — sized via position_sizing, validated via buy_confidence)
Catalyst
7.0/10data confidence 100%| Component | Sub-score |
|---|---|
| erm | 5.0 |
| earnings history | 10.0 |
| earnings timing | 5.0 |
| surprise avg | 10.0 |
| news activity | 5.0 |
- ▸Perfect beat streak: 4Q
- ▸Earnings in 3 days
How the verdict was assembled
Engine trigger
Earnings in 3 days. Wait until post-earnings.
Engine technical detail
verdict_path:
L3:NEWS_BLOCK|ENTRY_STICKY:PRIOR_STILL_VIABLEPassed (3)
- 8K:CLEAN
- SEMI_CYCLE_PEAK:CLEAR
- MATERIALS_CYCLE_PEAK:CLEAR
Failed (4)
- MOMENTUM:1.9<4.5
- ASYMMETRY:1.4<1.5@spot
- INSIDER:0.39%=HEAVY
- EARNINGS_PROXIMITY:3d<=7d
Warning (0)
none
Reward-to-Risk
1.36
Upside
+14.2%
Downside
10.5%
Sizing output
STARTER
Setup— — No clear chart pattern; technical signals are mixed
EdgeNo clear edge — No clear edge identified
SuitabilityAggressive — MCap $1.4B<$5B
Investment implication
A recent news event triggered an L3 news-block on the verdict path. Trigger: Earnings in 3 days. Wait until post-earnings. The 10-dimension scores remain Growth at 10.0 (strongest), but MOMENTUM:1.9<4.5 also fails — the news block is the proximate trigger, not the sole driver.
The strongest dimensions are Growth at 10.0, Technical at 7.4, and Catalyst at 7.0; the weakest are Momentum at 1.9, Insider at 2.9, and Risk (lower is worse) at 3.6. The V9 engine flagged 4 failed gates, producing an asymmetric reward-to-risk of 1.36 and an engine sizing output of STARTER.
What would invalidate the thesis
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1Exceptional Revenue Growth Rate
Trip ifRevenue growth falls below 30% per year for 2 consecutive reported quarters.
- P2Improving Earnings Beat Cadence
Trip ifEPS surprise falls below 0% for 2 consecutive quarters.
- P3Severe Cash Burn Viability Risk
Trip ifFree cash flow as a percentage of revenue improves above negative 40% for 2 consecutive quarters, demonstrating the cash-burn concern is materially diminished.
- P4Pullback In Uptrend Not Confirmed
Trip if200-day moving average slope turns negative for more than 20 consecutive trading days.